Detalhe da pesquisa
1.
Real-world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA-SWITCH study.
Aliment Pharmacol Ther
; 58(1): 60-70, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37089065
2.
Initial management of intraabdominal abscesses and preventive strategies for abscess recurrence in penetrating Crohn's disease: a national multicenter study based on ENEIDA registry.
J Crohns Colitis
; 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930823